A method for weakening the expression of gene hemB of Corynebacterium glutamicum and increasing the yield of ALA

By inserting specific DNA sequences into Corynebacterium glutamicum to weaken HemB expression and combining with the optimized ALAS gene, the problem of HemB expression regulation in the existing technology was solved, and the ALA yield was improved, showing a concise and efficient Methods to improve the synthesis of ALA.

CN118755749BActive Publication Date: 2024-11-26ZHONGNONG KERUI BIOTECHNOLOGY RESEARCH CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411244362.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-11-26
Estimated Expiration
2044-09-06

AI Technical Summary

Technical Problem

In Corynebacterium glutamicum, it is difficult for the prior art to effectively weaken HemB gene expression to improve 5-aminolevulinic acid (ALA) production. Traditional methods such as promoter replacement and degradation subtag technology have complexity and instability, which is difficult to Finely regulate enzyme protein expression.

Method used

By inserting a specific DNA sequence (such as w24) between the start codon of the HemB gene (such as w24), weakening HemB expression, and combining the optimized ALAS gene hemA sequence, the recombinant expression vector is constructed into the strain to achieve HemB expression Weakening, thereby increasing ALA production.

Benefits of technology

This method concisely and efficiently reduces ALA metabolic efficiency, improves ALA yield, is more stable and controllable than traditional methods, avoids the complexity and uncertainty of enzyme protein expression, and improves the feasibility of synthetic biology research.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118755749B_ABST
    Figure CN118755749B_ABST
Patent Text Reader

Abstract

The present invention relates to the field of agricultural biotechnology, and in particular to a gene weakening method of Corynebacterium glutamicum. hemB The present invention adopts the method of expressing and increasing ALA production. hemB The introduction of different DNA sequences between the start codon and the second codon weakened HemB expression, reduced ALA metabolic efficiency, and thus increased ALA production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of agricultural biotechnology, and in particular to a gene weakening method of Corynebacterium glutamicum. hemB Methods for expressing and increasing ALA production. Background Art

[0002] Gene expression regulation in biological cells is a complex process involving multiple factors and fine-tuned regulatory mechanisms. In the process of rationally designing cell metabolic pathways to improve the synthesis level of target compounds, it is often necessary to reshape the naturally existing metabolic flux in the cell factory. Typically, the metabolic flux in the synthesis pathway of the target compound is enhanced while the metabolic flux in the degradation pathway is reduced, which requires the truncation or weakening of the key metabolic links in the compound degradation pathway. Relatively speaking, metabolic pathway truncation is relatively simple and can be achieved by knocking out specific genes in the metabolic pathway. For metabolic flux weakening, it is often achieved by replacing the original promoter of the key gene in the metabolic pathway with a weak promoter to reduce the expression level of the key enzyme protein. In the actual research process, the method of using promoter replacement to weaken enzyme protein expression has great disadvantages, especially when the original promoter itself is weak in activity, it will be difficult to screen for promoters with weaker transcription initiation activity. In addition, another way to weaken metabolic flux is the degradation sub-tag technology, that is, adding a degradation sub-tag that is easily recognized and degraded by proteases to the end of the key enzyme protein in the metabolic pathway, accelerating the degradation of the enzyme protein, thereby reducing the abundance of the enzyme protein, thereby weakening and reducing the metabolic flux. However, the degradation subtag technology also has disadvantages. For example, most known degradation subtags are large (usually more than 100 amino acids), which limits their convenience in protein research and application; the degradation efficiency of degradation subtags is affected by many factors, and the efficiency of degradation subtags is unstable or difficult to predict, which increases the complexity and uncertainty of enzyme proteins coupled to degradation subtags. Therefore, designing and screening elements that weaken the expression of target proteins is one of the core issues in the process of synthetic biology research.

[0003] Corynebacterium glutamicum is an important industrial strain and the main producer of various amino acids such as glutamic acid, threonine, and lysine. In the application of Corynebacterium glutamicum to synthesize amino acids, it is necessary to reshape the synthesis and metabolic pathways of amino acids to increase the synthesis flux of the target product and reduce the metabolic flux of the target product, thereby increasing the synthesis level of the target product. In the pathway of using Corynebacterium glutamicum to produce 5-aminolevulinic acid (ALA), the gene hemB The encoded 5-aminolevulinic acid dehydratase (HemB) is the first key enzyme protein for ALA to be further metabolized into downstream products. Reducing the expression of HemB is beneficial to increasing the synthesis level of 5-aminolevulinic acid dehydratase. Summary of the invention

[0004] The purpose of the present invention is to provide a gene that weakens Corynebacterium glutamicum hemB Methods for expressing and increasing ALA production.

[0005] A gene of a weakened Corynebacterium glutamicum according to the present invention hemB The method for expressing and increasing the yield of ALA comprises the following steps: inserting a DNA sequence such as a nucleotide sequence as shown in SEQ ID NO: 2 or SEQ ID NO: 3 into the gene of the Corynebacterium glutamicum hemB (SEQ ID NO: 4) between the start codon ATG and the second codon to obtain the gene hemB Weakened Corynebacterium glutamicum.

[0006] A gene for weakening Corynebacterium glutamicum hemB A method for expressing and increasing ALA production, the method comprising the further steps of:

[0007] Optimization of the gene encoding 5-aminolevulinic acid synthase ALAS based on codon preference of Corynebacterium glutamicum hemA Sequence, get optimized gene hemA , and synthesize;

[0008] Constructing a gene containing the optimized hemA A recombinant expression vector;

[0009] The optimized gene hemA The gene is introduced into the recombinant expression vector hemB In weakened Corynebacterium glutamicum.

[0010] The present invention adopts hemB Different DNA sequences were introduced between the start codon and the second codon to weaken the expression of HemB, reduce the metabolic efficiency of ALA, and thus increase the yield of ALA. Compared with the current strategy of using antisense RNA to weaken the expression of HemB or other genes, the use of DNA sequences that weaken gene expression is simpler in strain construction and fermentation condition control. BRIEF DESCRIPTION OF THE DRAWINGS

[0011] Figure 1 Shows the growth phenotypes of different strains on solid LB, among which, 1: C. glutamicum hemB-w24,2: C. glutamic hemB-w18,3: C. glutamicum hemB-w9,4: C. glutamicum hemBm;

[0012] Figure 2 Displays the supernatant of fermentation broth of different strains, among which, 1: C. glutamicum -pXJM19,2: C. glutamicum hemB-w24-hemA,3: C. glutamicum hemBm-hemA;

[0013] Figure 3 Displays different strains and ALA content, among which, 1: C. glutamicum -pXJM19,2: C. glutamicum hemB-w24-hemA,3: C. glutamicum hemBm-hemA. DETAILED DESCRIPTION

[0014] The technical solution of the present application is described below in conjunction with specific embodiments, which are used in the following embodiments:

[0015] 1. Strains and Plasmids

[0016] Corynebacterium glutamicum C. glutamicum ATCC 13032, plasmid pXJM19 was obtained commercially;

[0017] 2. Culture medium

[0018] LB medium (g / L): yeast powder 5, peptone 10, NaCl 10;

[0019] Bovine brain heart sorbitol (BHIS) medium (g / L): bovine brain heart extract powder 37, sorbitol 91, pH 7.0;

[0020] Fermentation medium (g / L): 60 g glucose, 20 g ammonium sulfate, 2.5 g potassium dihydrogen phosphate, 0.6 g magnesium sulfate heptahydrate, 30 g corn steep liquor, 0.025 g ferrous sulfate heptahydrate, 0.025 g manganese sulfate monohydrate, 1 g urea, 2 g molasses, pH 6.5, the culture medium was sterilized at 121°C for 20 min, and agar powder was added to a final concentration of 1.5%–2.0% when preparing solid culture medium.

[0021] Example 1 Construction of HemB expression weakened strains containing different DNA sequences

[0022] The DNA sequences used to weaken HemB expression are divided into:

[0023] w9: 5'-CTAAGGTCC-3' (SEQ ID NO: 1);

[0024] w18: 5'-CTAAGGTCCTATCCCTA-3' (SEQ ID NO: 2);

[0025] w24:5'-CTAAGGTCCCTATCCCTAAGGCTA-3' (SEQ ID NO: 3).

[0026] Insert the above DNA sequences into the gene hemB (SEQ ID NO: 4) between the start codon ATG and the second codon, thereby achieving hemB The expression intensity is weakened to varying degrees. Taking w24 as an example, the process of constructing a strain containing w24 with weakened HemB expression is as follows:

[0027] Corynebacterium glutamicum C . glutamic ATCC 13032 chromosome was used as a template to amplify the 5-aminolevulinic acid dehydratase gene using the following primers: hemB-LF1 (SEQ ID NO: 5), hemB-LR24 (SEQ ID NO: 6), hemB-RF24 (SEQ ID NO: 7), hemB-RR1 (SEQ ID NO: 8), hemB-RF2 (SEQ ID NO: 9), and hemB-RR2 (SEQ ID NO: 10), respectively. hemB DNA fragment 1 ( hemB Add 24 bp DNA sequence between the start codon ATG and the second codon of the DNA fragment), DNA fragment 2 (containing the gDNA synonymous mutation DNA sequence), and DNA fragment 3. Using hemB-LF1 (SEQ ID NO: 5) and hemB-RR2 (SEQ ID NO: 10) as primers, DNA fragment 1, DNA fragment 2, and DNA fragment 3 were fused by Overlap-PCR to obtain DNA fragment hemB-w24.

[0028] Gene hemB, SEQ ID NO: 4:

[0029]

[0030] hemB-LF1:

[0031] 5'-TGATGGGTCTTGTTGTTGGCGTACCAGAACTGATCGACGCTCT-3' (SEQ ID NO: 5) and

[0032] hemB-LR24:

[0033] 5'-TAGCCTTAGGGATAGGGACCTTAGCATTGCTTGTAACCTTTGCTCTCT -3' (SEQ ID NO: 6);

[0034] hemB-RF24:

[0035] 5'-CTAAGGTCCCTATCCCTAAGGCTAAGCACTTCTTCTGATTACTCCCAC-3' (SEQ ID NO: 7) and

[0036] hemB-RR1: 5-GTCCTCTGTATGTTGATAAACGCCCGGCATGGAG-3' (SEQ ID NO: 8);

[0037] hemB-RF2:

[0038] 5'-GCGTTTATCAACATACAGAGGACTCGCTGCTGCGTGCCGCCCA-3' (SEQ ID NO: 9) and

[0039] hemB-RR2: 5'-AGTATCTTCCTGGCATCTTCCAGTCGCAGGATCTTGCTGGTAG-3' (SEQ IDNO: 10).

[0040] Using plasmid pYJ1 as a template, a DNA fragment (named ori-crRNA) including pA15 ori, J23119 promoter, and crRNA was amplified using primers (pA15-F (SEQ ID NO: 11), hemB / crRNA-R (SEQ ID NO: 12)).

[0041] pA15-F: 5'-CTGGAAGATGCCAGGAAGATACT-3' (SEQ ID NO: 11),

[0042] hemB / crRNA-R:

[0043] 5'-CTCTCATCCGCCAAAACAGCCAGCAGCGAATCTTCAGTGTGCTGAATCTACAACAGTAGAAATTCGGATCC-3' (SEQ ID NO: 12).

[0044] (3) Use endonuclease Apa I and Aar I digested the plasmid pYJ1 and recovered the large DNA fragment. The recovered DNA fragment, hemB-w24, and ori-crRNA were recombined using a DNA seamless recombination kit. The recombinant product was transformed E. coli Top10 competent cells were used to screen transformants using LB medium containing 50 μg / mL kanamycin, and the plasmid in the positive transformants was extracted and named pYJ1-hemB-w24.

[0045] (4) The plasmid pYJ1-hemB-w24 was introduced into the competent cells of Corynebacterium glutamicum 13032 by electroporation, and the transformants were screened with LB medium containing 25 μg / mL kanamycin. The transformants containing the plasmid pYJ1-hemBm were verified using hemB-VF (SEQ ID NO: 13) and hemB-VR24 (SEQ ID NO: 14) as primers, and the PCR product was ~ 0.7 kb. According to the method of Chinese invention patent ZL202210276549.8, the plasmid pYJ1-hemB-w24 in the positive transformants was eliminated to obtain the target strain, which was named C. glutamicum hemB-w24.

[0046] hemB-VF: 5'-GACCGCTGAAGAACTGGGACT-3' (SEQ ID NO: 13), hemB-VR24: 5'-TAGCCTTAGGGATAGGGACCTTAG-3' (SEQ ID NO: 14).

[0047] According to the above method, in the gene hemB The strains constructed by inserting w9 and w18 between the start codon ATG and the second codon of were named: C. glutamicum hemB-w9, C. glutamicum hemB-w18; at the same time constructed in the gene hemB Strains without DNA sequence inserted between the start codon ATG and the second codon C. glutamicum hemBm served as a control strain.

[0048] Example 2 HemB expression weakened strain and growth phenotype

[0049] ALA is a precursor of heme necessary for the normal growth of Corynebacterium glutamicum cells, and HemB is the first key enzyme protein to metabolize ALA. Weakened HemB expression reduces the intracellular HemB content, and the corresponding ALA metabolism rate is lower than that of normal cells, thereby reducing the cell growth rate. C. glutamicum hemBm, C. glutamicum hemB-w9, C. glutamic hemB-w18 and C. glutamicum hemB-w24 was inoculated into liquid LB medium and cultured at 37°C until turbidity. The diluted culture was suspended on solid LB medium and cultured at 37°C.

[0050] The experimental results show that C. glutamicum hemB-w9 and control strains C. glutamicum The colonies of hemBm were smaller than those of Figure 1 ), indicating that the introduction of sequence w9 did not significantly affect hemB The expression level and the growth rate of the strain did not decrease significantly. C. glutamicum hemB-w18 and C. glutamicum The colony size of hemB-w24 was similar to that of the control strain and was significantly smaller than that of the control strain. C. glutamicum Colonies of hemBm ( Figure 1 ), indicating that the introduction of sequences w18 and w24 weakened hemB The expression level of ALA was reduced, which reduced the content of heme and other products in the cell that are further metabolized by ALA and necessary for cell growth, thereby affecting the cell growth rate.

[0051] Example 3 HemB expression weakened strain and ALA synthesis

[0052] HemB is the first enzyme protein in ALA metabolism. The decrease in its expression will correspondingly reduce the degradation rate of ALA, thereby increasing the ALA yield. ALA is a precursor substance for the synthesis of chlorophyll and heme, and is widely used in agriculture, medicine, animal husbandry and other fields. Using microorganisms to efficiently synthesize ALA is currently an economical and environmentally friendly strategy for preparing ALA. Overexpression of 5-aminolevulinic acid synthase ALAS in microbial cells can effectively increase the level of ALA synthesis. R. palustris Gene encoding 5-aminolevulinic acid synthase ALAS hemA Sequence, synthesize, and optimize the gene hemA The nucleotide sequence is shown in SEQ ID NO:15. hemA through Psst I and XbaI was then ligated with plasmid pXJM19 treated with the same endonuclease to construct plasmid pXJM19-hemA.

[0053] Optimized hemA The sequence of SEQ ID NO: 15:

[0054]

[0055] because C. glutamicum hemB-w18 and C. glutamicum hemB-w24 was selected because the strains were similar in growth phenotype. C. glutamicum The plasmid pXJM19-hemA was introduced into the strains by electroporation. C. glutamicum hemBm and C. glutamicum hemB-w24, construct strain C. glutamicum hemBm-hemA and C. glutamicum hemB-w24-hemA. At the same time, plasmid pXJM19 was introduced into the strain C. glutamicum 13032, construct strain C. glutamicum -pXJM19 served as a control.

[0056] Pick the strains separately C. glutamicum -pXJM19, C. glutamicum hemBm-hemA and C. glutamic The colony of hemB-w24-hemA was inoculated into 20 mL of liquid BHIS medium containing 25 μg / mL kanamycin and cultured at 30°C with shaking for 36 h. The culture was inoculated into 100 mL of fermentation medium at 10% inoculum and cultured at 30°C with shaking for ~8 h, then IPTG was added to a final concentration of 0.1 mM and glycine to a final concentration of 6 g / L. After 48 h of fermentation, the 5-ALA content in the fermentation was determined.

[0057] Take 300 μL of the fermentation supernatant after appropriate dilution and add it to 400 μL of sodium acetate buffer (add 57 mL of glacial acetic acid to 82g of anhydrous sodium acetate and dilute to 1L with ultrapure water), then add 35 μL of acetylacetone, mix well and boil in boiling water for 15 minutes. After cooling to room temperature, add 735 μL of Ehrlich's reagent (add 8 mL of 70% perchloric acid to 1g of p-dimethylaminobenzaldehyde and dilute to 50mL with glacial acetic acid), color for 10 minutes and measure the absorbance at a wavelength of 554nm. Calculate the ALA content according to the standard curve and convert it into the ALA content in the fermentation broth.

[0058] After the fermentation of the strain is completed, the fermentation supernatant is collected by centrifugation. C. glutamicum -pXJM19 fermentation broth supernatant is lighter in color, strain C. glutamicum The supernatant of hemB-w24-hemA fermentation broth was light brown, while C. glutamic The supernatant of hemBm-hemA fermentation broth is dark red ( Figure 2 ). Analyze the reasons: strainsC. glutamic -pXJM19 does not introduce genes hemA The expression unit, the intracellular ALA synthesis level is at a normal level, and the corresponding ALA metabolites such as heme and other porphyrin ring structure substances (red) are low in content, so the color of the fermentation broth supernatant is lighter. C. glutamicum For hemBm-hemA, the expression level of HemA in cells is higher, and the content of ALA metabolites such as heme and other porphyrin ring structure substances is increased, so the color of the fermentation broth supernatant is darker. C. glutamicum The ALA synthesis level in hemB-w24-hemA was increased, but the ALA metabolism was reduced due to the weakened expression of HemB, the first enzyme in the ALA metabolic pathway, and the content of porphyrin ring structure substances was relatively low. C. glutamicum hemBm-hemA is low, so the color of the fermentation broth supernatant is also weaker.

[0059] To further confirm the addition of attenuated genes hemB After the DNA sequence was expressed, the ALA content in the fermentation supernatant of the above strain was determined. Figure 3 As shown, strain C. glutamicum -The ALA content in the supernatant of pXJM19 fermentation broth is ~10 mg / L, C. glutamicum The ALA content in the supernatant of hemBm-hemA fermentation broth was ~0.4 g / L. C. glutamicum The ALA content in the supernatant of hemBm-hemA fermentation broth was ~1.2 g / L ( Figure 3 ). The above experimental results show that weakening the expression of key genes is conducive to the efficient synthesis of target products.

[0060] The above embodiments are only used to understand the technical solution of the present application and do not limit the protection scope of the present application.

Claims

1. A gene for weakening Corynebacterium glutamicum hemB A method for expressing and increasing ALA production, characterized in that The method comprises the following steps: inserting a nucleotide sequence such as a DNA sequence shown in SEQ ID NO: 2 or SEQ ID NO: 3 into the gene of Corynebacterium glutamicum hemB Between the start codon ATG and the second codon, the gene hemB Attenuated Corynebacterium glutamicum, wherein the gene hemB The nucleotide sequence is shown in SEQ ID NO:

4.

2. The weakened gene of Corynebacterium glutamicum according to claim 1 hemB A method for expressing and increasing ALA production, characterized in that The method comprises the further steps of: Optimization of the gene encoding 5-aminolevulinic acid synthase ALAS based on codon preference of Corynebacterium glutamicum hemA Sequence, get optimized gene hemA , and synthesize; Constructing a gene containing the optimized hemA A recombinant expression vector; The optimized gene hemA The gene is introduced into the recombinant expression vector hemB In weakened Corynebacterium glutamicum.

3. The gene of the weakened Corynebacterium glutamicum according to claim 2 hemB A method for expressing and increasing ALA production, characterized in that The optimized gene hemA The nucleotide sequence is shown in SEQ ID NO:15.

Citation Information

Patent Citations

  • Method for weakening hemB gene expression to increase yield of 5-aminolevulinic acid synthesized by escherichia coli

    CN104830748A

  • Epoxysuccinic acid hydrolase encoding gene and application thereof

    CN106434713A

  • DNA element for high-throughput in vitro protein synthesis

    CN109022478A

  • Method for improving expression quantity of 5-aminolevulinic acid

    CN114369562A

  • Engineering strain with high yield of 5-aminolevulinic acid and construction method of strain with high yield of 5-aminolevulinic acid

    CN115747125A